Cargando…
Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
Lung cancer is a complex disease that often manifests at the point when treatment is not effective. Introduction of blood-based complementary diagnostics using molecular markers may enhance early detection of this disease and help reduce the burden of lung cancer. Here we evaluated the diagnostic po...
Autores principales: | Zaporozhchenko, Ivan A., Morozkin, Evgeny S., Skvortsova, Tatyana E., Ponomaryova, Anastasia A., Rykova, Elena Yu, Cherdyntseva, Nadezhda V., Polovnikov, Evgeny S., Pashkovskaya, Oksana A., Pokushalov, Evgeny A., Vlassov, Valentin V., Laktionov, Pavel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074500/ https://www.ncbi.nlm.nih.gov/pubmed/27768748 http://dx.doi.org/10.1371/journal.pone.0165261 |
Ejemplares similares
-
Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2018) -
Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors
por: RAHMANI SAMANI, Mahsa, et al.
Publicado: (2021) -
miR-96 and miR-183 differentially regulate neonatal and adult postinfarct neovascularization
por: Castellan, Raphael F.P., et al.
Publicado: (2020) -
A mouse model of miR-96, miR-182 and miR-183 misexpression implicates miRNAs in cochlear cell fate and homeostasis
por: Weston, Michael D., et al.
Publicado: (2018) -
Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers
por: Rykova, Elena, et al.
Publicado: (2017)